100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothYou Searched
Nalsign 50mg Tablet
Hab Pharmaceuticals and Research Ltd.
₹734
Our Recommendation
Naltivia 50mg Tablet 10s
1,978+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Opioid dependence / Alcohol addiction
Customers also bought
More About Nalsign
Benefits
In Opioid dependence : Opioids are prescribed to treat pain. With prolonged use, the body may become dependent on them and cause withdrawal symptoms, which makes it difficult to stop taking them. Nalsign 50mg Tablet helps prevent these cravings that lead to opioid dependence and also helps the person to refrain from taking them repeatedly.In Alcohol addiction Nalsign 50mg Tablet is a medicine used, along with social support and counseling, to help people recover from alcohol addiction and to avoid having the urge to drink alcohol again. Nalsign 50mg Tablet starts working from the very first dose and is a very safe and effective way of treating alcohol addiction. show moreshow less
Side Effects
Side effects of Nalsign Tablet The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Nalsign Joint pain Muscle pain Headache Vomiting Weakness Nausea Abdominal pain Anxiety Nervousness Restlessness Sleep disorder Fatigue Sleepiness
How to use
How to use Nalsign Tablet Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Nalsign 50mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
How Nalsign Tablet works Nalsign 50mg Tablet is an opioid antagonist. It works by blocking the euphoric feelings (highs) that you may experience after taking opiates and alcohol. This reduces craving and helps you remain off of them.
Safe: No harmful side effects are associated with consuming alcohol alongside Nalsign 50mg Tablet
Nalsign 50mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Nalsign 50mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Nalsign 50mg Tablet may cause side effects which could affect your ability to drive.Nalsign 50mg Tablet may make you feel tired or dizzy. This may affect your driving ability.
Nalsign 50mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nalsign 50mg Tablet may be needed. Doctor consultation is advised.
Nalsign 50mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Nalsign 50mg Tablet may be needed. Doctor consultation is advised.Regular monitoring of liver function tests is advisable while you are taking this medicine.
What if I forget to take it?
If a dose of Nalsign 50mg Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
Manufacturer Address
308, T.V. Industrial Estate, S.K. Ahire Marg, Behind Glaxo Lab, Worli, Mumbai 400 030
References
Schuckit MA. Ethanol and Methanol. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 642-43
Schumacher MA, Basbaum AI, Way WL. Opioids Analgesics & Antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 547-48
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 953-54
Mayo Clinic. Naltrexone (06 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (6 Apr. 2019)
Naltrexone hydrochloride (20 Feb. 2024)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
